Читать книгу Anti-Aging Therapeutics Volume XVI - A4M American Academy - Страница 40

1.Mahmud K. Natural hormone therapy for menopause. Gynecological Endocrinology. 2010;26;81-85.

2.Diamanti-Kandarakis E, Lambrinoudaki I, Economou F, Christou M, Piperi C, Papavassiliou AG, Creatsas G. Androgens associated with advanced glycation end-products in postmenopausal women. Menopause. 2010;17:1-5.

3.O'Connor KA, Ferrell R, Brindle E, Trumble B, Shofer J, Holman DJ, Weinstein M. Progesterone and ovulation across stages of the transition to menopause. Menopause. 2009;16:1178-1187.

4.Panay N, Al-Azzawi F, Bouchard C, Davis SR, Eden J, Lodhi I, Rees M, Rodenberg CA, Rymer J, Schwenkhagen A, Sturdee DW. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric. 2010;13:121-131.

5.Berent-Spillson A, Persad CC, Love T, Tkaczyk A, Wang H, Reame NK, Frey KA, Zubieta JK, Smith YR. Early menopausal hormone use influences brain regions used for visual working memory. Menopause. 2010;17:692-699.

6.Newhouse PA, Dumas J, Wilkins H, Coderre E, Sites CK, Naylor M, Benkelfat C, Young SN. Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women. Menopause. 2010;17:860-873.

7.Lord C, Engert V, Lupien SJ, Pruessner JC. Effect of sex and estrogen therapy on the aging brain: a voxel-based morphometry study. Menopause. 2010;17:846-851.

8.Wiacek M, Hagner W, Zubrzycki IZ. Measures of menopause driven differences in levels of blood lipids, follicle-stimulating hormone, and luteinizing hormone in women aged 35 to 60 years: National Health and Nutrition Examination Survey III and National Health and Nutrition Examination Survey 1999-2002 study. Menopause. 2010;18:1-7. .

9.Bryan KJ, Mudd JC, Richardson SL, Chang J, Lee HG, Zhu X, Smith MA, Casadesus G. Down-regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits. J Neurochem. 2010;112:870-881.

10.Kåss AS, Lea TE, Torjesen PA, Gulseth HC, Førre ØT. The association of luteinizing hormone and follicle-stimulating hormone with cytokines and markers of disease activity in rheumatoid arthritis: a case-control study. Scand J Rheumatol. 2010;39:109-117.

11.Anderer P, Saletu B, Gruber D, Linzmayer L, Semlitsch HV, Saletu-Zyhlarz G, Brandstätter N, Metka M, Huber J. Age-related cognitive decline in the menopause: effects of hormone replacement therapy on cognitive event-related potentials. Maturitas. 2005;51:254-269.

12.Gibbs RB. Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr Rev. 2010;31:224-253.

13.Short RA, Bowen RL, O'Brien PC, Graff-Radford NR. Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc. 2001;76:906-909.

14.Al-Hader AA, Tao YX, Lei ZM, Rao CV. Fetal rat brains contain luteinizing hormone/human chorionic gonadotropin receptors. Early Pregnancy. 1997;3:323-329.

15.Wich BK, Carnes M. Menopause and the aging female reproductive system. Endocrinol Metab Clin North Am. 1995;24:273-295.

16.Foster JD, Strauss JF 3rd, Paavola LG. Cellular events involved in hormonal control of receptor-mediated endocytosis: regulation occurs at multiple sites in the low density lipoprotein pathway, including steps beyond the receptor. Endocrinology. 1993;132:337-350.

17.Davis JD, Podolanczuk A, Donahue JE, Stopa E, Hennessey JV, Luo LG, Lim YP, Stern RA. Thyroid hormone levels in the prefrontal cortex of post-mortem brains of Alzheimer's disease patients. Curr Aging Sci. 2008;1:175-181.

18.El Kholy M, Fahmi ME, Nassar AE, Selim S, Elsedfy HH. Prevalence of minor musculoskeletal anomalies in children with congenital hypothyroidism. Horm Res. 2007;68:272-275.

19.Sözay S, Gökçe-Kutsal Y, Celiker R, Erbas T, Başgöze O. Neuroelectrophysiological evaluation of untreated hyperthyroid patients. Thyroidology. 1994;6:55-69.

20.Cakir M, Samanci N, Balci N, Balci MK. Musculoskeletal manifestations in patients with thyroid disease. Clin Endocrinol (Oxf). 2003;59:162-167.

21.Øverlie I, Moen MH, Holte A, Finset A. Androgens and estrogens in relation to hot flushes during the menopausal transition. Maturitas. 2002;41:69-77.

22.Bowen RL, Smith MA, Harris PL, Kubat Z, Martins RN, Castellani RJ, Perry G, Atwood CS. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res. 2002;70:514-518.

23.Williams MB, Hernandez J, Thompson I. Luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength. J Urol. 2005;173:1067-1071.

24.Cummings DC, Wall SR, Gailbraith MA, Belcastro AN. Reproductive hormone responses to resistance exercise. Med Sci Sports Exerc. 1987;19:234-238.

25.Hazeldine J, Arlt W, Lord JM. Dehydroepiandrosterone as a regulator of immune cell function. J Steroid Biochem Mol Biol. 2010;120:127-136.

26.Hogervorst E, Bandelow S, Moffat SD. Increasing testosterone levels and effects on cognitive functions in elderly men and women: a review. Curr Drug Targets CNS Neurol Disord. 20054:531-540.

27.Schiavone FE, Rietschel RL, Sgoutas D, Harris R. Elevated free testosterone levels in women with acne. Arch Dermatol. 1983;119:799-802.

28.Wichmann MW, Ayala A, Chaudry IH. Male sex steroids are responsible for depressing macrophage immune function after trauma-hemorrhage. Am J Physiol. 1997;273:C1335-C13340.

29.Mason AS. The menopause: the events of the menopause. R Soc Health J. 1976;96:70-71.